Discovery of PANoptosis-related signatures correlates with immune cell infiltration in psoriasis
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies five PANoptosis-related signatures (PANoptosis-sig) as potential biomarkers for psoriasis, revealing two distinct molecular subtypes and novel therapeutic targets for this inflammatory skin disease.
Area Of Science
- Immunodermatology
- Cellular Biology
- Molecular Medicine
Background
- Psoriasis is a chronic inflammatory skin condition characterized by frequent relapses.
- Dysregulation of keratinocyte apoptosis is a key factor in psoriasis pathogenesis.
- PANoptosis, a cell death process involving pyroptosis, apoptosis, and necroptosis, is implicated but its role in psoriasis remains unclear.
Purpose Of The Study
- To identify PANoptosis-related molecular signatures in psoriasis.
- To develop predictive and diagnostic models for psoriasis using these signatures.
- To explore psoriasis molecular subtypes based on PANoptosis signatures.
Main Methods
- Transcriptional and protein level analysis of skin tissues from psoriasis patients and healthy controls.
- Identification of five PANoptosis-related signatures (TYMP, S100A8, S100A9, NAMPT, LCN2).
- Enrichment analysis, single-cell transcriptome analysis, predictive model construction, and unsupervised consensus clustering.
Main Results
- Five key PANoptosis-sig were identified, enriched in inflammatory pathways like IL-17 signaling.
- TYMP and NAMPT showed broad cell expression, while LCN2, S100A8, and S100A9 were highly expressed in keratinocytes.
- Two distinct psoriasis molecular subtypes were identified, differing in immune cell infiltration and sensitivity to immune checkpoints.
Conclusions
- The identified PANoptosis-sig serve as potential biomarkers for psoriasis diagnosis and prognosis.
- These signatures offer novel therapeutic targets for psoriasis treatment.
- The study enhances understanding of PANoptosis mechanisms in psoriasis development and heterogeneity.
Related Concept Videos
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

